Table 2.
Small ORFs (<15 kDa) with no assigned function, which are highly conserved in Brucella species.
B. abortus 2308 ORFa | B. suis 1330 ORFa | B. melitensis 16M ORFa | Annotationb | In vitro CIc | In vivo CId |
---|---|---|---|---|---|
BAB2_0068e | BRA0069 | BMEII0025 | Type IV secretion system protein virB1 | 0.0023 | 0.0001 |
BAB1_0061 | BR0064 | BMEI1881 | hypothetical protein | 0.7493 | 1.2039 |
BAB1_0355 | BR0325 | BMEI1597 | COG1380 LrgA family protein [general function prediction only] | 1.3655 | 0.0153 |
BAB1_0513 | BR0488 | BMEI1447 | hypothetical protein | 5.6537 | 1.0448 |
BAB1_0581 | BR0557 | BMEI1376 | COG3654; prophage maintenance system killer protein [general function prediction only] | 1.8387 | 0.5577 |
BAB1_0626 | BR0602 | BMEI1339 | hypothetical protein | 3.6877 | N |
BAB1_0743 | BR0725 | BMEI1227 | hypothetical protein [possible relationship to acetyltransferases] | 0.6340 | 0.6160 |
BAB1_0992 | BR0973 | BMEI1005 | hypothetical protein | 1.1191 | 0.4853 |
BAB1_1106 | BR1083 | BMEI0899 | COG3617; prophage antirepressor [possible function in transcription] | 1.2815 | 0.6963 |
BAB1_1194 | BR1173 | BMEI0813 | hypothetical protein | 1.2322 | 0.3799 |
BAB1_1204 | BR1181 | BMEI0806 | hypothetical protein | 1.3258 | 0.4248 |
BAB1_1262 | BR1241 | BMEI0751 | hypothetical protein | N | 1.5608 |
BAB1_1390 | BR1370 | BMEI0633 | COG0239; possible integral membrane protein | N | 1.8630 |
BAB1_1392 | BR1372 | BMEI0631 | COG3467; predicted flavin nucleotide binding protein [general function prediction only] | N | 1.4038 |
BAB1_1743 | BR1730 | BMEI0308 | hypothetical protein | 0.6744 | N |
BAB1_1748 | BR1736 | BMEI0304 | COG1607, Acyl-CoA hydrolase [Lipid metabolism] | N | 1.3140 |
BAB1_1939 | BR1938 | BMEI0127 | hypothetical protein | 0.4634 | 0.4569 |
BAB1_2041 | BR2041 | BMEI0030 | DUF188 superfamily | 2.6421 | 0.5280 |
BAB2_0160 | BRA0162 | BMEII1078 | COG4893; uncharacterized protein conserved in bacteria | 0.6152 | 1.1670 |
BAB2_0170 | BRA0175 | BMEII1067 | DUF465 superfamily; putative cytosolic protein | 0.2584 | N |
BAB2_0761 | BRA0476 | BMEII0789 | hypothetical protein | 0.5177 | N |
BAB2_0726 | BRA0512 | BMEII0758 | Pfam01873; YbgT-like protein | 0.0079 | 0.0001 |
BAB2_0470 | BRA0769 | BMEII0522 | Pfam05635; family of hypothetical proteins | 0.0002 | 0.0025 |
BAB2_0450 | BRA0787 | BMEII0503 | hypothetical protein | 0.0435 | 0.0180 |
BAB2_0415 | BRA0819 | BMEII0468 | hypothetical protein | 1.0595 | 1.2254 |
BAB2_0400 | BRA0836 | BMEII0454 | hypothetical protein | 1.0501 | 1.8400 |
BAB2_0232 | BRA1000 | BMEII0296 | hypothetical protein | N | 0.9205 |
BAB2_1072 | BRA1113 | BMEII0186 | pemK family protein [possible regulator] | 5.1792 | 0.5605 |
BAB2_1087 | BRA1130 | BMEII0169 | Hypothetical protein [flagellar locus] | N | 1.0841 |
BAB2_1136 | BRA1177 | BMEII0118 | DUF1634 superfamily | 0.2300 | 0.4828 |
ORF number from NCBI.
Followed B. suis 1330 assignment.
Competitive index (CI): Calculated as Mean Mutants/WT from at least three experiments. N: Not tested.
Competitive index (CI): Calculated as Mean Mutants/WT in spleen of 2–5 mice. N: Not tested.
A previously characterized virB1 mutant (BA41) serves as attenuation phenotype control.